{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:17:40Z","timestamp":1793758660611,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Monash Institute of Neurological Disease"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.parkreldis.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:44:48Z","timestamp":1536241488000},"page":"133-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Inferring the long duration response to levodopa in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-6006","authenticated-orcid":false,"given":"Kanae","family":"Nagao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesvaran","family":"Ganga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5456-8676","authenticated-orcid":false,"given":"Jane E.","family":"Alty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Clissold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"McColl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina A.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Kempster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.09.002_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM196702162760703","article-title":"Aromatic amino acids and modification of Parkinsonism","volume":"276","author":"Cotzias","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(84)90003-0","article-title":"Dopamine metabolism in the central nervous system after discontinuation of L-Dopa therapy in patients with Parkinson disease","volume":"66","author":"Ogasahara","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1212\/WNL.44.9.1617","article-title":"Effect of brief levodopa holidays on the short-duration response to levodopa: evidence for tolerance to the antiparkinsonian effects","volume":"44","author":"Nutt","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ana.410420311","article-title":"Short-and long-duration responses to levodopa during the first year of levodopa therapy","volume":"42","author":"Nutt","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00002826-199710000-00003","article-title":"The long-duration action of levodopa may be due to a postsynaptic effect","volume":"20","author":"Barbato","year":"1997","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/1531-8257(200005)15:3<485::AID-MDS1010>3.0.CO;2-F","article-title":"Time course of loss of clinical benefit after withdrawal of levodopa\u2013carbidopa and bromocriptine in early Parkinson's disease","volume":"15","author":"Hauser","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.410390504","article-title":"The response to levodopa in Parkinson's disease: imposing pharmacological law and order","volume":"39","author":"Nutt","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/1531-8257(199907)14:4<605::AID-MDS1009>3.0.CO;2-H","article-title":"Evolution of motor fluctuations in Parkinson's disease: a longitudinal study over 6 years","volume":"14","author":"Reardon","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/mds.10244","article-title":"Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease","volume":"17","author":"McColl","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/jnnp.52.6.718","article-title":"Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease","volume":"52","author":"Kempster","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental State\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/mds.25335","article-title":"Longitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase","volume":"28","author":"Ganga","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib13","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib14","unstructured":"R Foundation for Statistical Computing, Vienna, Austria, 2017.."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib15","author":"Pinheiro"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib16","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2009"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/jnnp.2011.240366","article-title":"The natural history of treated Parkinson's disease in an incident, community based cohort","volume":"82","author":"Evans","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/archneur.58.10.1611","article-title":"Functional decline in Parkinson's disease","volume":"58","author":"Jankovic","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib19","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/01.wnl.0000183359.50822.f2","article-title":"Progression of motor impairment and disability in Parkinson disease. A population-based study","volume":"65","author":"Alves","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney multicenter study of Parkinson's disease: non-L-Dopa\u2013responsive problems dominate at 15 years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awq059","article-title":"Relationships between age and late progression of Parkinson's disease: a clinico-pathological study","volume":"133","author":"Kempster","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJM198911163212004","article-title":"Effect of deprenyl on the progression of disability in early Parkinson's disease","volume":"321","author":"The Parkinson Study Group","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib23","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"The Parkinson Study Group","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A double-blind, delayed start trial of rasagiline in Parkinson's disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.parkreldis.2011.03.014","article-title":"The long-duration response to levodopa: phenomenology, potential mechanisms and clinical implications","volume":"17","author":"Anderson","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.24961","article-title":"The missing, the short, and the long: levodopa responses and dopamine actions","volume":"82","author":"Albin","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib27","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib28","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1212\/WNL.45.8.1613","article-title":"Long-duration response to levodopa","volume":"45","author":"Nutt","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.09.002_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.410380308","article-title":"The subacute levodopa test for evaluating long-duration response in Parkinson's disease","volume":"38","author":"Quattrone","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2018.09.002_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/WNL.54.1.247","article-title":"Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD","volume":"54","author":"Nutt","year":"2000","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018303870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018303870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T10:30:55Z","timestamp":1556793055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018303870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":30,"alternative-id":["S1353802018303870"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.09.002","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inferring the long duration response to levodopa in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}